The Ghana Association of Medical Laboratory Scientists (GAMLS) has raised concerns over a recent outbreak of cerebrospinal meningitis (CSM) in parts of Northern Ghana.
As frontline professionals in disease detection and management, GAMLS emphasized the crucial role of laboratory testing in containing the spread of this highly infectious and life-threatening disease.
Cerebrospinal meningitis is a severe condition that causes inflammation of the meninges the protective membranes surrounding the brain and spinal cord. If not promptly diagnosed and treated, it can lead to severe complications, including neurological damage and death.
In response to the outbreak, GAMLS has outlined a series of measures to combat the disease, including enhanced disease surveillance, scaling up laboratory testing, strict infection prevention protocols, and intensified public health education.
In a statement issued on February 4, 2025, the association called on healthcare facilities to prioritize laboratory diagnostics and urged authorities to ensure the provision of necessary logistics and resources for laboratories, especially in affected regions.
The association also used the opportunity to advocate for strengthening microbiological laboratory capacities nationwide.
It emphasized that improved laboratory infrastructure and capabilities would not only enhance outbreak detection and response efforts for CSM but also for other emerging infectious diseases.
GAMLS reaffirmed its commitment to supporting the national response to the outbreak and called on all stakeholders, including the government and public health institutions, to collaborate in mitigating the spread of CSM in Ghana.
With the ongoing outbreak posing a significant public health risk, GAMLS urges the public to stay informed, recognize early symptoms, and seek medical attention promptly. “Together, we can safeguard the health and well-being of our communities,” the association concluded.
